GE HealthCare Technologies Inc.: Business Overview, Financials & Competitive Analysis
GE HealthCare Technologies Inc. scores 7/10 on the AskCyborg Cyborg Score (Strong). Well-positioned healthcare technology leader with AI-driven growth engines, attractive valuation, and strong earnings momentum entering 2026. GE HealthCare has underperformed the broader market but analysts are cautiously optimistic, with consensus being a 'Moderate Buy' and the stock potentially undervalued by 41%. The company is advancing AI-enabled imaging products.
What is GE HealthCare Technologies Inc.'s industry? GE HealthCare Technologies Inc. (gehealthcare.com) operates in Medical Devices & Diagnostics / Healthcare Technology. AskCyborg classifies GE HealthCare Technologies Inc. under Medical Devices & Diagnostics / Healthcare Technology in its company registry.
GE HealthCare Technologies designs, develops, and manufactures medical technology, pharmaceutical diagnostics, and digital solutions, with a portfolio including diagnostic imaging systems, ultrasound devices, patient ...
Cyborg Score thesis
Well-positioned healthcare technology leader with AI-driven growth engines, attractive valuation, and strong earnings momentum...
Read the full analyst-debate transcript →Get the Latest GE HealthCare Technologies Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeGE HealthCare Technologies Inc. Overview
Pro stress-test →GE HealthCare Technologies designs, develops, and manufactures medical technology, pharmaceutical diagnostics, and digital solutions, with a portfolio including diagnostic imaging systems, ultrasound devices, patient monitoring equipment, imaging agents, and healthcare IT platforms. The company is a global medical technology leader focused on improving clinical outcomes through innovative imaging and diagnostic solutions.
Strategic Profile
Pro stress-test →GE HealthCare guides for 3-4% organic revenue growth in 2026 with adjusted EPS of $4.95-$5.15. Growth is expected from the Imaging and Pharmaceutical Diagnostics segments, ongoing innovation in cloud-first imaging, and integration of acquisitions like Intelerad. The company maintains a strong competitive position through AI-enabled products and a record backlog of orders.
Competitive Landscape
Pro stress-test →GE HealthCare competes primarily against Siemens Healthineers, Philips Healthcare, and Canon Medical Systems in medical imaging and diagnostic equipment. The company differentiates through its comprehensive portfolio spanning imaging, monitoring, anesthesia, and AI-enabled clinical software solutions, supported by strong R&D investment and strategic acquisitions.
Industry Context
GE HealthCare Technologies Inc. operates in Medical Devices & Diagnostics / Healthcare Technology.
Key facts
Founded: 2023 · Headquarters: Chicago, US · Revenue: $20.63B (2025 full year)